- Home
- EBS vs BME Comparison
EBS vs BME Comparison
Compare EBS & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBS | BME |
|---|---|---|
| Founded | 1998 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 663.3M | 534.8M |
| IPO Year | 2006 | N/A |
Fundamental Metrics
Financial Performance| Metric | EBS | BME |
|---|---|---|
| Price | $13.20 | $41.51 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 788.6K | 34.0K |
| Earning Date | 10-29-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.26% |
| EPS Growth | N/A | N/A |
| EPS | 1.35 | ★ 1.44 |
| Revenue | ★ $788,900,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $15.21 | N/A |
| P/E Ratio | ★ $9.51 | $28.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.02 | $35.53 |
| 52 Week High | $13.41 | $43.20 |
Technical Indicators
Market Signals| Indicator | EBS | BME |
|---|---|---|
| Relative Strength Index (RSI) | 67.74 | 60.82 |
| Support Level | $12.02 | $40.55 |
| Resistance Level | $12.90 | $41.46 |
| Average True Range (ATR) | 0.50 | 0.44 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 75.00 | 88.04 |
Price Performance
Historical ComparisonAbout EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.